Arrowgrass Capital Partners (US)’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-26,500
Closed -$2.46M 243
2017
Q4
$2.46M Buy
26,500
+26,235
+9,900% +$2.38M 0.02% 370
2017
Q3
$2.4M Sell
265
-150
-36% -$12.8K 0.02% 437
2017
Q2
$3.49M Sell
415
-3,184
-88% -$257K 0.03% 426
2017
Q1
$29.1M Buy
3,599
+3,333
+1,253% +$262K 0.3% 86
2016
Q4
$2M Buy
+266
New +$19.2K 0.02% 366
2015
Q4
Sell
-438
Closed -$2.83M 413
2015
Q3
$2.83M Sell
438
-315
-42% -$23.3K 0.05% 214
2015
Q2
$6.16M Buy
+753
New +$58.1K 0.09% 189

Other funds holding EMN

Arrowgrass Capital Partners (US)'s EMN Position: Q1 2018 in Review

Arrowgrass Capital Partners (US) sold out of Eastman Chemical (EMN) in Q1 2018, closing a stake of 3,448 shares — an estimated $319K sold.

Arrowgrass Capital Partners (US) first reported a position in EMN in Q3 2015 and held it in 6 quarters. The position peaked at $9.7M in Q1 2017. 703 funds tracked by Wall St. Rank hold EMN as of Q1 2018.

  • Arrowgrass Capital Partners (US) reported no remaining Eastman Chemical position as of Q1 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 3,448 Eastman Chemical shares in Q1 2018, an estimated $319K.
  • Arrowgrass Capital Partners (US) first reported a position in Eastman Chemical in Q3 2015 and held it in 6 quarters.
  • Arrowgrass Capital Partners (US)'s Eastman Chemical position peaked at $9.7M in Q1 2017.
  • 703 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.